IBDEI3GL ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,58182,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58182,1,3,0)
;;=3^Traumatic Glaucoma,Bilateral,Mild Stage
;;^UTILITY(U,$J,358.3,58182,1,4,0)
;;=4^H40.33X1
;;^UTILITY(U,$J,358.3,58182,2)
;;=^5005861
;;^UTILITY(U,$J,358.3,58183,0)
;;=H40.33X2^^272^2901^126
;;^UTILITY(U,$J,358.3,58183,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58183,1,3,0)
;;=3^Traumatic Glaucoma,Bilateral,Moderate Stage
;;^UTILITY(U,$J,358.3,58183,1,4,0)
;;=4^H40.33X2
;;^UTILITY(U,$J,358.3,58183,2)
;;=^5005862
;;^UTILITY(U,$J,358.3,58184,0)
;;=H40.33X3^^272^2901^127
;;^UTILITY(U,$J,358.3,58184,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58184,1,3,0)
;;=3^Traumatic Glaucoma,Bilateral,Severe Stage
;;^UTILITY(U,$J,358.3,58184,1,4,0)
;;=4^H40.33X3
;;^UTILITY(U,$J,358.3,58184,2)
;;=^5005863
;;^UTILITY(U,$J,358.3,58185,0)
;;=H40.33X4^^272^2901^124
;;^UTILITY(U,$J,358.3,58185,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58185,1,3,0)
;;=3^Traumatic Glaucoma,Bilateral,Indeterminate Stage
;;^UTILITY(U,$J,358.3,58185,1,4,0)
;;=4^H40.33X4
;;^UTILITY(U,$J,358.3,58185,2)
;;=^5005864
;;^UTILITY(U,$J,358.3,58186,0)
;;=H21.233^^272^2901^26
;;^UTILITY(U,$J,358.3,58186,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58186,1,3,0)
;;=3^Degeneration of Iris,Bilateral
;;^UTILITY(U,$J,358.3,58186,1,4,0)
;;=4^H21.233
;;^UTILITY(U,$J,358.3,58186,2)
;;=^5005189
;;^UTILITY(U,$J,358.3,58187,0)
;;=H40.61X1^^272^2901^40
;;^UTILITY(U,$J,358.3,58187,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58187,1,3,0)
;;=3^Drug-Induced Glaucoma,Right Eye,Mild Stage
;;^UTILITY(U,$J,358.3,58187,1,4,0)
;;=4^H40.61X1
;;^UTILITY(U,$J,358.3,58187,2)
;;=^5005907
;;^UTILITY(U,$J,358.3,58188,0)
;;=H40.013^^272^2901^59
;;^UTILITY(U,$J,358.3,58188,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58188,1,3,0)
;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Bilateral
;;^UTILITY(U,$J,358.3,58188,1,4,0)
;;=4^H40.013
;;^UTILITY(U,$J,358.3,58188,2)
;;=^5005726
;;^UTILITY(U,$J,358.3,58189,0)
;;=H40.012^^272^2901^60
;;^UTILITY(U,$J,358.3,58189,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58189,1,3,0)
;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Left Eye
;;^UTILITY(U,$J,358.3,58189,1,4,0)
;;=4^H40.012
;;^UTILITY(U,$J,358.3,58189,2)
;;=^5005725
;;^UTILITY(U,$J,358.3,58190,0)
;;=H40.011^^272^2901^61
;;^UTILITY(U,$J,358.3,58190,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58190,1,3,0)
;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Right Eye
;;^UTILITY(U,$J,358.3,58190,1,4,0)
;;=4^H40.011
;;^UTILITY(U,$J,358.3,58190,2)
;;=^5005724
;;^UTILITY(U,$J,358.3,58191,0)
;;=H40.023^^272^2901^84
;;^UTILITY(U,$J,358.3,58191,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58191,1,3,0)
;;=3^Open-Angle w/ Borderline Findings,Hi Risk,Bilateral
;;^UTILITY(U,$J,358.3,58191,1,4,0)
;;=4^H40.023
;;^UTILITY(U,$J,358.3,58191,2)
;;=^5005730
;;^UTILITY(U,$J,358.3,58192,0)
;;=H40.063^^272^2901^108
;;^UTILITY(U,$J,358.3,58192,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58192,1,3,0)
;;=3^Primary Angle-Closure w/o Glaucoma Damage,Bilateral
;;^UTILITY(U,$J,358.3,58192,1,4,0)
;;=4^H40.063
;;^UTILITY(U,$J,358.3,58192,2)
;;=^5005746
;;^UTILITY(U,$J,358.3,58193,0)
;;=H40.243^^272^2901^113
;;^UTILITY(U,$J,358.3,58193,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58193,1,3,0)
;;=3^Residual Stage Angle-Closure Glaucoma,Bilateral
;;^UTILITY(U,$J,358.3,58193,1,4,0)
;;=4^H40.243
;;^UTILITY(U,$J,358.3,58193,2)
;;=^5005845
;;^UTILITY(U,$J,358.3,58194,0)
;;=H40.043^^272^2901^121
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3GL 3952 printed Nov 22, 2024@17:58:30 Page 2
IBDEI3GL ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,58182,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,58182,1,3,0)
+4 ;;=3^Traumatic Glaucoma,Bilateral,Mild Stage
+5 ;;^UTILITY(U,$J,358.3,58182,1,4,0)
+6 ;;=4^H40.33X1
+7 ;;^UTILITY(U,$J,358.3,58182,2)
+8 ;;=^5005861
+9 ;;^UTILITY(U,$J,358.3,58183,0)
+10 ;;=H40.33X2^^272^2901^126
+11 ;;^UTILITY(U,$J,358.3,58183,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,58183,1,3,0)
+14 ;;=3^Traumatic Glaucoma,Bilateral,Moderate Stage
+15 ;;^UTILITY(U,$J,358.3,58183,1,4,0)
+16 ;;=4^H40.33X2
+17 ;;^UTILITY(U,$J,358.3,58183,2)
+18 ;;=^5005862
+19 ;;^UTILITY(U,$J,358.3,58184,0)
+20 ;;=H40.33X3^^272^2901^127
+21 ;;^UTILITY(U,$J,358.3,58184,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,58184,1,3,0)
+24 ;;=3^Traumatic Glaucoma,Bilateral,Severe Stage
+25 ;;^UTILITY(U,$J,358.3,58184,1,4,0)
+26 ;;=4^H40.33X3
+27 ;;^UTILITY(U,$J,358.3,58184,2)
+28 ;;=^5005863
+29 ;;^UTILITY(U,$J,358.3,58185,0)
+30 ;;=H40.33X4^^272^2901^124
+31 ;;^UTILITY(U,$J,358.3,58185,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,58185,1,3,0)
+34 ;;=3^Traumatic Glaucoma,Bilateral,Indeterminate Stage
+35 ;;^UTILITY(U,$J,358.3,58185,1,4,0)
+36 ;;=4^H40.33X4
+37 ;;^UTILITY(U,$J,358.3,58185,2)
+38 ;;=^5005864
+39 ;;^UTILITY(U,$J,358.3,58186,0)
+40 ;;=H21.233^^272^2901^26
+41 ;;^UTILITY(U,$J,358.3,58186,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,58186,1,3,0)
+44 ;;=3^Degeneration of Iris,Bilateral
+45 ;;^UTILITY(U,$J,358.3,58186,1,4,0)
+46 ;;=4^H21.233
+47 ;;^UTILITY(U,$J,358.3,58186,2)
+48 ;;=^5005189
+49 ;;^UTILITY(U,$J,358.3,58187,0)
+50 ;;=H40.61X1^^272^2901^40
+51 ;;^UTILITY(U,$J,358.3,58187,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,58187,1,3,0)
+54 ;;=3^Drug-Induced Glaucoma,Right Eye,Mild Stage
+55 ;;^UTILITY(U,$J,358.3,58187,1,4,0)
+56 ;;=4^H40.61X1
+57 ;;^UTILITY(U,$J,358.3,58187,2)
+58 ;;=^5005907
+59 ;;^UTILITY(U,$J,358.3,58188,0)
+60 ;;=H40.013^^272^2901^59
+61 ;;^UTILITY(U,$J,358.3,58188,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,58188,1,3,0)
+64 ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Bilateral
+65 ;;^UTILITY(U,$J,358.3,58188,1,4,0)
+66 ;;=4^H40.013
+67 ;;^UTILITY(U,$J,358.3,58188,2)
+68 ;;=^5005726
+69 ;;^UTILITY(U,$J,358.3,58189,0)
+70 ;;=H40.012^^272^2901^60
+71 ;;^UTILITY(U,$J,358.3,58189,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,58189,1,3,0)
+74 ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Left Eye
+75 ;;^UTILITY(U,$J,358.3,58189,1,4,0)
+76 ;;=4^H40.012
+77 ;;^UTILITY(U,$J,358.3,58189,2)
+78 ;;=^5005725
+79 ;;^UTILITY(U,$J,358.3,58190,0)
+80 ;;=H40.011^^272^2901^61
+81 ;;^UTILITY(U,$J,358.3,58190,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,58190,1,3,0)
+84 ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Right Eye
+85 ;;^UTILITY(U,$J,358.3,58190,1,4,0)
+86 ;;=4^H40.011
+87 ;;^UTILITY(U,$J,358.3,58190,2)
+88 ;;=^5005724
+89 ;;^UTILITY(U,$J,358.3,58191,0)
+90 ;;=H40.023^^272^2901^84
+91 ;;^UTILITY(U,$J,358.3,58191,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,58191,1,3,0)
+94 ;;=3^Open-Angle w/ Borderline Findings,Hi Risk,Bilateral
+95 ;;^UTILITY(U,$J,358.3,58191,1,4,0)
+96 ;;=4^H40.023
+97 ;;^UTILITY(U,$J,358.3,58191,2)
+98 ;;=^5005730
+99 ;;^UTILITY(U,$J,358.3,58192,0)
+100 ;;=H40.063^^272^2901^108
+101 ;;^UTILITY(U,$J,358.3,58192,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,58192,1,3,0)
+104 ;;=3^Primary Angle-Closure w/o Glaucoma Damage,Bilateral
+105 ;;^UTILITY(U,$J,358.3,58192,1,4,0)
+106 ;;=4^H40.063
+107 ;;^UTILITY(U,$J,358.3,58192,2)
+108 ;;=^5005746
+109 ;;^UTILITY(U,$J,358.3,58193,0)
+110 ;;=H40.243^^272^2901^113
+111 ;;^UTILITY(U,$J,358.3,58193,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,58193,1,3,0)
+114 ;;=3^Residual Stage Angle-Closure Glaucoma,Bilateral
+115 ;;^UTILITY(U,$J,358.3,58193,1,4,0)
+116 ;;=4^H40.243
+117 ;;^UTILITY(U,$J,358.3,58193,2)
+118 ;;=^5005845
+119 ;;^UTILITY(U,$J,358.3,58194,0)
+120 ;;=H40.043^^272^2901^121
